Lyt Inc. announced the official launch of LytSpace, a wearable intelligence platform with multiple patent-pending technologies, alongside the first wave of LytBand pre-order customers who begin onboarding immediately. LytSpace introduces three innovations: Genome AI, Perpetual Full-Resolution Charting, and Deep Machine-Learning Biomarker Synthesis. Genome AI is a conversational intelligence engine that reconfigures the device in response to natural-language requests, orchestrating up to 150 individual sensor parameters, adjusting sampling speeds, power allocation, and sensing modality priorities. The LytBand Pro tracks over 150 markers, while the LytBand Dimension variant extends to nearly 1,000 markers. Genome AI tailors the sensor fabric to the individual, accounting for age, lifestyle, stated goals, and skin tone, as optical sensors must adjust calibration for melanin concentration. Lyt Inc. has filed patents with the United States Patent and Trademark Office covering these methods. Genome AI is also the first wearable AI to reference a corpus of over 300 million clinical data points spanning ClinicalTrials.gov, PubMed, PubMed Central, FDA. The LytBand is the only wearable powered by ambient light with an active solar surface area up to ten times greater than any competing device. The platform runs machine-learning models on advanced computing from NVIDIA.